05/07 | ADAGIO THERAPEUTICS : Announces Results of Annual Meeting of Stockholders and Evolution of.. |  |
05/07 | ADAGIO THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Events, Finan.. |  |
05/07 | SECTOR UPDATE : Health Care Stocks Struggle Tuesday |  |
05/07 | SECTOR UPDATE : Health Care Stocks Retreating in Tuesday Trade |  |
05/07 | SECTOR UPDATE : Health Care |  |
05/07 | Adagio Therapeutics Appoints David Hering Permanent CEO and Director |  |
05/07 | Mithril Capital's Ajay Royan Sends Letter Thanking Adagio Therapeutics Shareholders for.. |  |
05/07 | Adagio Announces David Hering Named Permanent Chief Executive Officer and Director |  |
05/07 | Adagio Therapeutics, Inc. Appoints David Hering Permanent Chief Executive Officer |  |
05/07 | Adagio Therapeutics, Inc. Appoints David Hering as Director |  |
01/07 | Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board o.. |  |
01/07 | Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board o.. |  |
30/06 | ADAGIO THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K) |  |
30/06 | Howard Mayer, M.D. Notifies Adagio Therapeutics, Inc. of His Decision to Resign from th.. |  |
24/06 | ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) dropped from Russell 2500 Growth Index |  |
24/06 | ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) added to Russell Microcap Index |  |
24/06 | ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) dropped from Russell 2000 Growth Index |  |
24/06 | ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) added to Russell Microcap Value Index |  |
24/06 | ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) dropped from Russell Small Cap Comp Growth Inde.. |  |
24/06 | ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) dropped from Russell 3000 Growth Index |  |
24/06 | ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) added to Russell 3000E Index |  |
24/06 | ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) dropped from Russell 3000E Growth Index |  |
24/06 | ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) added to Russell 3000E Value Index |  |
22/06 | ADAGIO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) |  |
22/06 | Declaration of Voting Results by Adagio Therapeutics, Inc |  |
22/06 | Adagio Therapeutics, Inc. Elects Class I Directors |  |
21/06 | Adagio Therapeutics, Inc. Announces Resignation of Anand Shah from the Board of Directo.. |  |
21/06 | ADAGIO THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K) |  |
13/06 | ADAGIO THERAPEUTICS : Results from the Phase 2/3 Randomized, Double-Blind, Placebo-Control.. |  |
13/06 | ADAGIO THERAPEUTICS : ADG20, a half-life–extended monoclonal antibody in development.. |  |
06/06 | Mithril Capital Management LLC Solicits Proxies from Shareholders of Adagio Therapeutic.. |  |
19/05 | ADAGIO THERAPEUTICS : Material Event - Form 8-K |  |
19/05 | ADAGIO THERAPEUTICS, INC. : Other Events (form 8-K) |  |
19/05 | Adagio Therapeutics Provides Information to Shareholders |  |
13/05 | ADAGIO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition .. |  |
13/05 | Adagio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31.. |  |
13/05 | Adagio Therapeutics Reports Q1 Loss, Higher Operating Expenses |  |
13/05 | Adagio Therapeutics Reports First Quarter 2022 Financial Results |  |
26/04 | Adagio Therapeutics Inc Solicits Proxies from Shareholders |  |
25/04 | Mithril Capital Provides Information to Shareholders of Adagio Therapeutics |  |
14/04 | Adagio Therapeutics Pauses EUA Request for COVID-19 Drug Candidate Adintrevimab; Shares.. |  |
14/04 | Adagio Therapeutics Provides Update on Timing of Adintrevimab EUA Request |  |
14/04 | Adagio Therapeutics, Inc. Provides Update on Timing of Adintrevimab EUA Request |  |
11/04 | Mithril Capital Management LLC Solicits Proxies from Shareholders of Adagio Therapeutic.. |  |
31/03 | Adagio Therapeutics annonce que l'ADG20 (adintrevimab) est le premier anticorps monoclo.. |  |
31/03 | Adagio Therapeutics anuncia que ADG20 (adintrevimab) es el primer anticuerpo monoclonal.. |  |
31/03 | Adagio Therapeutics gibt bekannt, dass ADG20 (Adintrevimab) der erste monoklonale Antik.. |  |
31/03 | Adagio Therapeutics anuncia que ADG20 (adintrevimab) es el primer anticuerpo monoclonal.. |  |
31/03 | ADAGIO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition .. |  |
31/03 | NORTH AMERICAN MORNING BRIEFING : Stock Futures -3- |  |
30/03 | Mithril Capital Nominates Candidates to the Board of Adagio Therapeutics |  |
30/03 | SECTOR UPDATE : Health Care Stocks Close Slightly Lower |  |
30/03 | SECTOR UPDATE : Health Care Stocks Still Trying to Find Direction |  |
30/03 | Top Midday Gainers |  |
30/03 | Wall Street Set for Downbeat Session, US Q4 GDP Growth Revised Down to 6.9% |  |
30/03 | SECTOR UPDATE : Health Care Stocks Lean Lower Pre-Bell Wednesday |  |
30/03 | Thiel-backed venture firm Mithril seeks to nominate candidates for Adagio's board |  |
30/03 | SECTOR UPDATE : Health Care |  |
30/03 | ADAGIO THERAPEUTICS : Announces ADG20 (adintrevimab) is the First Monoclonal Antibody to M.. |  |
30/03 | Top Premarket Gainers |  |
30/03 | Adagio Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31,.. |  |
30/03 | Mithril Capital Management Communicates with Adagio Therapeutics |  |
30/03 | Adagio Therapeuticsts Meets Primay Endpoints in Phase2/3 Studies for Treatment of COVID.. |  |
30/03 | Adagio Therapeutics Announces ADG20 (adintrevimab) is the First Monoclonal Antibody to .. |  |
30/03 | Adagio Therapeutics Announces ADG20 (adintrevimab) is the First Monoclonal Antibody to .. |  |
21/03 | ADAGIO THERAPEUTICS : AMENDED AND RESTATED EMPLOYMENT AGREEMENT - Form 8-K |  |
21/03 | ADAGIO THERAPEUTICS : AMENDED AND RESTATED EMPLOYMENT AGREEMENT - Form 8-K/A |  |
21/03 | ADAGIO THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Events, Finan.. |  |
21/03 | ADAGIO THERAPEUTICS, INC. Change in Directors or Principal Officers, Financial Stateme.. |  |
21/03 | Adagio Therapeutics, Inc. Appoints Jane Pritchett Henderson as Chief Business Officer |  |
21/03 | ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) dropped from S&P Biotechnology Select Industry .. |  |
18/03 | Adagio Therapeutics, Inc. Announces 2022 Annual Meeting of Stockholders |  |
18/03 | Adagio Therapeutics, Inc. Announces 2022 Annual Meeting of Stockholders |  |
01/03 | ADAGIO THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K) |  |
01/03 | Adagio Therapeutics, Inc. Announces Executive Changes, Effective March 25, 2022 |  |